White label ELPA - ClinicalTrials.eu

Study of lurbinectedin and irinotecan in adults and young adults with advanced desmoplastic small round cell tumor

Recruiting

2 1 1 1
Investigated diseases:
- Desmoplastic small round cell tumour
Investigated drugs:
- Lurbinectedin
- Irinotecan Hydrochloride Trihydrate
Treatment with trastuzumab deruxtecan, capecitabine and bevacizumab for patients with HER2-positive metastatic colorectal cancer

Recruiting

2 1 1 1
Investigated diseases:
- Colorectal cancer metastatic
Investigated drugs:
Study of ficerafusp alfa and pembrolizumab as first treatment for patients with PD-L1-positive recurrent or metastatic head and neck cancer

Recruiting

4 1 1
Investigated diseases:
- Squamous cell carcinoma of head and neck
Investigated drugs:
- Pembrolizumab
+5
Study of dupilumab injections to reduce airway inflammation in adults aged 40-85 with chronic obstructive pulmonary disease

Recruiting

3 1 1
Investigated diseases:
- Chronic obstructive pulmonary disease
Investigated drugs:
- Dupilumab
- Salbutamol
+4
Study of MTX-463 compared to placebo to assess its safety and effectiveness in adults with idiopathic pulmonary fibrosis

Recruiting

2 1 1
Investigated diseases:
- Idiopathic pulmonary fibrosis
Investigated drugs:
- Sodium Chloride
Study of Zolbetuximab combined with Paclitaxel and Ramucirumab for patients with previously treated CLDN18.

Recruiting

2 1 1 1
Investigated diseases:
- Oesophageal adenocarcinoma
Investigated drugs:
- Zolbetuximab
Comparing intranasal sufentanil and ketamine for severe acute trauma-related pain management in children admitted to pediatric emergency care

Recruiting

2 1 1 1
Investigated diseases:
- Traumatic pain
Investigated drugs:
Study of NX-5948 in adults with relapsed or resistant chronic lymphocytic leukemia and small lymphocytic lymphoma who previously received BTK inhibitor and BCL-2 inhibitor treatment

Recruiting

2 1 1
Investigated diseases:
Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Recruiting

3 1 1
Investigated diseases:
Investigated drugs:
- Bi 690517
- Empagliflozin
+17
Study of patritumab deruxtecan versus drug combination in patients with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer

Recruiting

3 1 1 1
Investigated diseases:
- Hormone receptor positive HER2 negative breast cancer
- Hormone receptor positive breast cancer
Investigated drugs:
+1

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies